Patents by Inventor Helen Toni Jun

Helen Toni Jun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody Agents Directed Against Lymphocyte Activation Gene-3 (LAG-3) and Uses Thereof
    Publication number: 20240158495
    Abstract: The disclosure provides antibody agents that bind to a Lymphocyte Activation Gene-3 (LAG-3) protein. Particular immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide sequences are explicitly provided. Also provided are related nucleic acids, vectors, compositions, and methods of using anti-LAG-3 antibody agents to treat a disorder or disease that is responsive to LAG-3 inhibition, such as, for example, cancer or an infectious disease.
    Type: Application
    Filed: January 12, 2023
    Publication date: May 16, 2024
    Inventors: Helen Toni Jun, Marilyn Kehry, Peter Bowers, David J. King, Dmitri Bobilev, Srimoyee Ghosh, Baochuan Huang, David Jenkins
  • ANTIBODY AGENTS DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE-3 (LAG-3) AND USES THEREOF
    Publication number: 20220135670
    Abstract: The disclosure provides antibody agents that bind to a Lymphocyte Activation Gene-3 (LAG-3) protein. Particular immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide sequences are explicitly provided. Also provided are related nucleic acids, vectors, compositions, and methods of using anti-LAG-3 antibody agents to treat a disorder or disease that is responsive to LAG-3 inhibition, such as, for example, cancer or an infectious disease.
    Type: Application
    Filed: April 27, 2018
    Publication date: May 5, 2022
    Inventors: Helen Toni Jun, Marilyn Kehry, Peter Bowers, David J. King, Dmitri Bobilev, Srimoyee Ghosh, Baochuan Huang, David Jenkins
  • Antibodies Directed Against Lymphocyte Activation Gene 3 (LAG-3)
    Publication number: 20210095026
    Abstract: The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to a protein encoded by the Lymphocyte Activation Gene-3 (LAG-3). The invention provides a LAG-3-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. The invention also provides related vectors, compositions, and methods of using, the LAG-3-binding, agent to treat a disorder or disease that is responsive to LAG-3 inhibition, such as cancer or an infectious disease.
    Type: Application
    Filed: October 19, 2020
    Publication date: April 1, 2021
    Inventors: Helen Toni Jun, Marilyn Kehry, Peter Bowers, David J. King
  • Antibodies directed against lymphocyte activation gene 3 (LAG-3)
    Patent number: 10836824
    Abstract: The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to a protein encoded by the Lymphocyte Activation Gene-3 (LAG-3). The invention provides a LAG-3-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. The invention also provides related vectors, compositions, and methods of using the LAG-3-binding agent to treat a disorder or disease that is responsive to LAG-3 inhibition, such as cancer or an infectious disease.
    Type: Grant
    Filed: February 3, 2016
    Date of Patent: November 17, 2020
    Assignee: ANAPTYSBIO, INC.
    Inventors: Helen Toni Jun, Marilyn Kehry, Peter Bowers, David J. King
  • ANTIBODIES DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE 3 (LAG-3)
    Publication number: 20190256596
    Abstract: The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to a protein encoded by the Lymphocyte Activation Gene-3 (LAG-3). The invention provides a LAG-3-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. The invention also provides related vectors, compositions, and methods of using the LAG-3-binding agent to treat a disorder or disease that is responsive to LAG-3 inhibition, such as cancer or an infectious disease.
    Type: Application
    Filed: May 1, 2019
    Publication date: August 22, 2019
    Applicant: AnaptysBio, Inc.
    Inventors: Helen Toni JUN, Marilyn KEHRY, Peter BOWERS, David J. KING
  • ANTIBODIES DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE 3 (LAG-3)
    Publication number: 20180127496
    Abstract: The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to a protein encoded by the Lymphocyte Activation Gene-3 (LAG-3). The invention provides a LAG-3-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. The invention also provides related vectors, compositions, and methods of using the LAG-3-binding agent to treat a disorder or disease that is responsive to LAG-3 inhibition, such as cancer or an infectious disease.
    Type: Application
    Filed: February 3, 2016
    Publication date: May 10, 2018
    Inventors: Helen Toni JUN, Marilyn KEHRY, Peter BOWERS, David J. KING
  • ANTIBODIES DIRECTED AGAINST DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBER 1 (DDR1)
    Publication number: 20170158762
    Abstract: The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to Discoidin Domain Receptor Family, Member 1 (DDR1). The invention provides a DDR1-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. The invention also provides related vectors, compositions, and methods of using the DDR1-binding agent to treat a DDR1-mediated disease.
    Type: Application
    Filed: January 27, 2015
    Publication date: June 8, 2017
    Inventors: Helen Toni Jun, Robert A. Horlick, David J. King